The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation

被引：8
|
作者：
Bang, Si Ra [2 ]
Kim, Yoon Hee [1 ]
Kim, Gaab Soo [3 ]
机构：
[1] Chungnam Natl Univ Hosp, Dept Anesthesiol & Pain Med, Taejon 301721, South Korea
[2] Inje Univ, Haeundae Paik Hosp, Dept Anesthesiol & Pain Med, Pusan, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea
来源：
CLINICAL TRANSPLANTATION | 2011年 / 25卷 / 03期
关键词：
6% HES 130; 0; 4 (hydroxyethyl starch) solution; end-stage liver disease; hemodilution; liver transplantation; thrombelastograph; COAGULATION; SURGERY; SALINE; DISEASE; COAGULOPATHY; ACTIVATION; COLLOIDS; GELATIN;
D O I：
10.1111/j.1399-0012.2010.01294.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Introduction: The aim of this study was to determine the effects of in vitro hemodilution with 6% HES (130/0.4) solution on thrombelastograph (R) (TEG) parameters in whole blood samples from patients with end-stage liver disease (ESLD). Methods: Enrollment consisted of 95 patients with ESLD undergoing liver transplantation. Blood was diluted by 11%, 22%, and 33% with 6% HES (130/0.4) solution. Normal saline was used as a control diluent. Results: When blood was diluted by 33% with normal saline, only the reaction time (r) was increased (p < 0.0001) compared to the baseline value. When blood was diluted with 6% HES (130/0.4), 11% dilution decreased maximum amplitude (MA) (p = 0.003) compared to baseline. At 33% dilution, the r (p < 0.0001, vs. baseline) and K (p < 0.0001, vs. baseline; p < 0.0001, vs. normal saline) increased, and the MA, alpha angle, and coagulation index (p < 0.0001, vs. baseline; p < 0.0001, vs. normal saline) decreased. Conclusion: Hemodilution with 6% HES (130/0.4) solution results in TEG abnormalities even with 11% hemodilution, in whole blood samples of patients with ESLD undergoing liver transplantation.
引用
收藏
页码：450 / 456
页数：7
相关论文
共 50 条
  • [41] Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution
    Ickx, BE
    Bepperling, F
    Melot, C
    Schulman, C
    Van der Linden, PJ
    BRITISH JOURNAL OF ANAESTHESIA, 2003, 91 (02) : 196 - 202
  • [42] Immune and inflammatory role of hydroxyethyl starch 130/0.4 and fluid gelatin in patients undergoing coronary surgery
    Ozturk, Tulun
    Onur, Ece
    Cerrahoglu, Mustafa
    Calgan, Mehmet
    Nizamoglu, Funda
    Civi, Melek
    CYTOKINE, 2015, 74 (01) : 69 - 75
  • [43] Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers
    Waitzinger, J
    Bepperling, F
    Pabst, G
    Opitz, J
    Muller, M
    Baron, JF
    CLINICAL DRUG INVESTIGATION, 1998, 16 (02) : 151 - 160
  • [44] Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers
    Josef Waitzinger
    Frank Bepperling
    Günther Pabst
    Jens Opitz
    Margarete Müller
    Jean François Baron
    Clinical Drug Investigation, 1998, 16 : 151 - 160
  • [45] Coagulation, oncotic and haemodilutional effects of a third-generation hydroxyethyl starch (130/0.4) solution in horses
    Viljoen, A.
    Page, P. C.
    Fosgate, G. T.
    Saulez, M. N.
    EQUINE VETERINARY JOURNAL, 2014, 46 (06) : 739 - 744
  • [46] Effects of hydroxyethyl starch 6 % (130/0.4) on blood loss during cesarean delivery: a propensity-matched analysis
    Terkawi, Abdullah S.
    Larkin, Sarah K.
    Tsang, Siny
    Sheeran, Jessica S.
    Tiouririne, Mohamed
    JOURNAL OF ANESTHESIA, 2016, 30 (05) : 796 - 802
  • [47] Effects of hydroxyethyl starch 6 % (130/0.4) on blood loss during cesarean delivery: a propensity-matched analysis
    Abdullah S. Terkawi
    Sarah K. Larkin
    Siny Tsang
    Jessica S. Sheeran
    Mohamed Tiouririne
    Journal of Anesthesia, 2016, 30 : 796 - 802
  • [48] Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass
    Hans, Gregory A.
    Hartstein, Gary
    Roediger, Laurence
    Hubert, Bernard
    Peters, Pierre
    Senard, Marc
    THROMBOSIS RESEARCH, 2015, 135 (05) : 984 - 989
  • [49] Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
    Adamik, Katja-Nicole
    Stoffel, Michael H.
    Tangermann, Simone
    de Breuyn Dietler, Bettina
    Stokar-Regenscheit, Nadine
    FRONTIERS IN VETERINARY SCIENCE, 2022, 8
  • [50] 6% Hydroxyethyl starch 130/0.4 versus 3% modified fluid gelatin for volume replacement in patients undergoing on pump cardiac surgery
    Deraedt, D.
    De Hert, S.
    De Decker, K.
    Cromheecke, S.
    De Paep, R.
    Ten Broecke, P.
    Van der Linden, P.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 83 - 83
12345